InvestSMART

Micro-X Limited (ASX:MX1)

ALERT: Price-sensitive ASX Announcement for MX1
Current share price for MX1 : $0.027 -0.011 (-28.95%)+
Announcement
Release
3 Jun 2026 12:06PM
Price at Release
$0.038
Full Release
download
Summary
Micro-X Limited announced the commencement of a multi-centre pilot study using their Head CT scanner, marking a significant milestone with the world's first CNT Cone Beam CT human images taken at the Royal Melbourne Hospital. The study aims to compare the image quality of Micro-X’s miniature scanner with standard CT imaging in patients with various brain conditions. It involves a blind study of 108 patients and is expected to take six to nine months to complete. A second test bench has been manufactured for the Royal Adelaide Hospital. The Head CT scanner is designed for rapid stroke assessment and is being developed to fit into standard ambulances. The project has received funding from the Australian Government and involves collaboration with the Australian Stroke Alliance and international institutions.
Key Points
  • World-first CNT Cone Beam CT human imaging conducted at Royal Melbourne Hospital.
  • Pilot study to evaluate image quality compared to standard CT in brain pathologies.
  • Expected study duration is six to nine months with 108 patients.
  • Second Head CT test bench manufactured for Royal Adelaide Hospital.
  • Micro-X Head CT supports rapid decision-making in acute stroke care.
  • Micro-X's system features a curved array of CNT X-ray tubes.
  • Device designed to fit into standard road ambulance weighing under 70kg.
  • Development funded by Australian Government's Medical Research Future Fund.
  • Australian Stroke Alliance and international collaborations involved.
  • Study aims to identify neuroimaging-based contraindications to stroke thrombolysis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.